Novel association of Vav2 and Nek3 modulates signaling through the human prolactin receptor

Molecular Endocrinology

Volumn 19, Issue 4, 2005, Pages 939-949

  Miller, Sommer L ^a   DeMaria, Jamie E ^b   Freier, David O ^c   Riegel, Angela M ^d   Clevenger, Charles V ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b GUILFORD PHARMACEUTICALS INC   (United States)

^c LYNCHBURG COLLEGE   (United States)

^d PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; NEVER IN MITOSIS A RELATED FAMILY KINASE; PROLACTIN RECEPTOR; PROTEIN KINASE; PROTEIN NEK3; PROTEIN P56; PROTEIN SERINE THREONINE KINASE; PROTEIN VAV1; PROTEIN VAV2; RAC1 PROTEIN; SERINE; TYROSINE; UNCLASSIFIED DRUG; VAV PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL MOTILITY; CHO CELL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; UPREGULATION;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CASEINS; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; IMMUNOPRECIPITATION; ONCOGENE PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-VAV; RAC1 GTP-BINDING PROTEIN; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

CRICETINAE; CRICETULUS GRISEUS;

EID: 15444365135     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0443     Document Type: Article

References (61)

1. Clevenger CV, Furth PA, Hankinson SE, Schuler LA 2003 The role of prolactin in mammary carcinoma. Endocr Rev 24:1-27
2. Coffin V, Binart N, Touraine P, Kelly PA 2002 Prolactin: the new biology of an old hormone. Annu Rev Physiol 64:47-67
3. Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT, Tomaszewski JE 1995 Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am J Pathol 146: 695-705
4. Ginsburg E, Vonderhaar BK 1995 Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 55:2591-2595
5. Brockman JL, Schroeder MD, Schuler LA 2002 PRL activates the cyclin d1 promoter via the jak2/stat pathway. Mol Endocrinol 16:774-784
6. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J 1994 Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57:353-361
7. Wennbo H, Gebre-Medhin M, Griti-Linde A, Ohlsson C, lsaksson OGP, Tornell J 1997 Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 100:2744-2751
8. Wennbo H, Tornell J 2000 The role of prolactin and growth hormone in breast cancer. Oncogene 19: 1072-1076
9. Horseman ND, Zhao W, Montecino-Rodriguiez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E, Dorshkind K 1997 Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16:6926-6935
10. Vomachka AJ, Pratt SL, Lockefeer JA, Horseman ND 2000 Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth. Oncogene 19:1077-1084
11. Lebrun JJ, Ali S, Sofer L, Ullrich A, Kelly PA 1994 Prolactin-induced proliferation Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J Biol Chem 269: 14021-14026
12. Rui H, Lebrun J-J, Kirken RA, Kelly PA, Farrar WL 1994 JAK2 activation and cell proliferation induced by anti-body-mediated prolactin receptor dimerization. Endocrinology 135:1299-1306
13. Das R, Vonderhaar BK 1996 Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res Treat 40:141-149
14. Clevenger CV, Torigoe T, Reed JC 1994 Prolactin induces rapid phosphorylation and activation of prolactin receptor associated Raf-1 kinase in a T-cell line. J Biol Chem 269:5559-5565
15. Das R, Vonderhaar BK 1996 Involvement of She, Grb2, Sos, and Ras in prolactin signal transduction in mammary epithelial cells. Oncogene 13:1139-1145
16. Maus MV, Reilly SC, Clevenger CV 1999 Prolactin as a chemoattractant for human breast carcinoma. Endocrinology 140:5447-5450
17. Kline JB, Moore DJ, Clevenger CV 2001 Activation and association of the Tec tyrosine kinase with the human prolactin receptor: mapping of a Tec/Vav1-receptor binding site. Mol Endocrinol 15:832-841
18. Abe K, Rossman KL, Liu B, Ritola KD, Chiang D, Campbell SL, Burridge K, Der CJ 2000 Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem 275:10141-10149
19. Liu BP, Burridge K 2000 Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not β1 integrins. Mol Cell Biol 20:7160-7169
20. Bustelo XR 2000 Regulatory and signaling properties of the Vav family. Mol Cell Biol 20:1461-1477
21. Schuebel KE, Bustelo XR, Nielsen DA, Song B-J, Barbacid M, Goldman D, Lee IJ 1996 Isolation and characterization of murine vav2, a member of the vav family of protooncogenes. Oncogene 13:363-371
22. Movilla N, Bustelo XR 1999 Biological and regulatory properties of Vav-3, an new member of the Vav family of oncoproteins. Mol Cell Biol 19:7870-7885
23. Adams JM, Houston H, Allen J, Lints T, Harvey R 1992 The hematopoietically expressed vav proto-oncogene shares homology with the db/GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene 7:611-618
24. Booden MA, Campbell SL, Der CJ 2002 Critical but distinct roles for the pleckstrin homology and cysteine-rich domains as positive modulators of Vav2 signaling and transformation. Mol Cell Biol 22:2487-2497
25. Aghazadeh B, Lowry WE, Huang XY, Rosen MK 2000 Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation. Cell 102:625-633
26. Bustelo XR 2002 Regulation of Vav proteins by intramolecular events. Front Biosci 7:d24-d30
27. Machide M, Mano H, Todokoro K 1995 Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain. Oncogene 11: 619-625
28. Servitja JM, Marinissen MJ, Sodhi A, Bustelo XR, Gutkind JS 2003 Rac1 function is required for Src-induced transformation. Evidence of a role for Tiam1 and Vav2 in Rac activation by Src. J Biol Chem 278:34339-34346
29. Tartare-Deckert S, Monthouel MN, Charvet C, Foucault I, Van Obberghen E, Bernard A, Altman A, Deckert M 2001 Vav2 activates c-fos serum response element and CD69 expression but negatively regulates nuclear factor of activated T cells and interleukin-2 gene activation in T lymphocyte. J Biol Chem 276:20849-20857
30. BCR/ABL. EMBO J 14:257-265
31. Clevenger CV, Ngo W, Sokol DL, Luger SM, Gewirtz AM 1995 Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J Biol Chem 270:13246-13253
32. Tamas P, Solti Z, Buday L 2001 Membrane-targeting is critical for the phosphorylation of Vav2 by activated EGF receptor. Cell Signal 13:475-481
33. Schuebel KE, Movilla N, Rosa JL, Bustelo XR 1998 Phosphorylation- dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J 17:6608-6621
34. Moores SL, Selfors LM, Fredericks J, Breit T, Fujikawa K, Alt F, Grugge JS, Swat W 2000 Vav family proteins couple to diverse cell surface receptors. Mol Cell Biol 20: 6364-6373
35. Tamas P, Solti Z, Bauer P, Illes A, Sipeki S, Bauer A, Farago A, Downward J, Buday L 2003 Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac. J Biol Chem 278: 5163-5171
36. Marignani PA, Carpenter CL 2001 Vav2 is required for cell spreading. J Cell Biol 154:177-186
37. Manser E, Loo R-H, Koh C-G, Zhao Z-S, Chen X-Q, Tan L, Tan I, Leung T, Lim L 1998 PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol Cell 1:183-192
38. Tanaka K, Nigg EA 1999 Cloning and characterization of the murine Nek3 protein kinase, a novel member of the NIMA family of putative cell cycle regulators. J Biol Chem 274:13491-13497
39. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR 1997 Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385:169-172
40. Ran J, Das B, Wei W, Van Aelst L, Mosteller RD, Khosravi-Far R, Westwick JK, Der CJ, Broek D 1997 Lck regulates Vav activation of members of the Rho family of GTPases. Mol Cell Biol 17:1346-1353
41. Miranti CK, Leng L, Maschberger P, Brugge JS, Shattil SJ 1998 Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1. Curr Biol 8:1289-1299
42. Salojin KV, Zhang J, Delovitch TL 1999 TCR and CD28 are coupled via ZAP-70 to the activation fo the Vav/Rac-1/PAK-1/p38 MAPK signaling pathway. J Immunol 163: 844-853
43. Lopez-Lago M, Lee H, Cruz C, Movilla N, Bustelo XR 2000 Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav. Mol Cell Biol 20:1678-1691
44. Grimley PM, Dong F, Rui H 1999 Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev 10:131-157
45. Faruqi TR, Gomez D, Bustelo XR, Bar-Sagi D, Reich NC 2001 Rac1 mediates STAT3 activation by autocrine IL-6. Proc Natl Acad Sci USA 98:9014-9019
46. Kodama A, Matozaki T, Fukuhara A, Kikyo M, Ichihashi M, Takai Y 2000 Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering. Mol Biol Cell 11: 2565-2575
47. Aznar S, Lacal JC 2001 Rho signals to cell growth and apoptosis. Cancer Lett 165:1-10
48. Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF 1999 Fetal anemia and apoptosis of red cell progenitors in Stat5a-/--5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98:181-191
49. Chen WY, Ramamoorthy P, Chen N, Sticca R, Wagner TE 1999 A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis. Clin Cancer Res 5:3583-3593
50. Beck MT, Peirce SK, Chen WY 2002 Regulation of bcl-2 gene expression in human breast cancer cells by prolactin and its antagonist, hPRL-G129R. Oncogene 21: 5047-5055
51. Ramamoorthy P, Sticca R, Wagner TE, Chen WY 2001 In vitro studies of a prolactin antagonist, hPRL-G129R in human breast cancer cells. Int J Oncol 18:25-32
52. Shigematsu H, Iwasaki H, Otsuka T, Ohno Y, Arima F, Niho Y 1997 Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activity. J Biol Chem 272: 14334-14340
53. Michel F, Grimaud L, Tuosto L, Acuto O 1998 Fyn and ZAP-70 are required for Vav phosphorylation in T cells stimulated by antigen-presenting cells. J Biol Chem 273: 31932-31938
54. Hall A 1998 Rho GTPases and the actin cytoskeleton. Science 279:509-514
55. Man J, Luby-Phelps K, Das B, Shiu X, Mosteller RD, Krishna UM, Falck JR, White MA, Broek D 1998 Role of substrates and products of PI 3-kinase in regulating activation of rac-related guanosine triphosphatases by Vav. Science 279:558-560
56. Aspenstrom P 1999 Effectors for the Rho GTPases. Curr Opin Cell Biol 11:95-102
57. Schuringa JJ, Jonk LJ, Dokter WH, Vellenga E, Kruijer W 2000 Interleukin-6-induced STATS transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components. Biochem J 347:89-96
58. Fun G, Wells JA 1995 Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J Biol Chem 270:13133-13137
59. Golemis EA, Serebriiskii I, Gyuris J, Brent R 1997 Interaction trap/two-hybrid system to identify interacting proteins. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current protocols in molecular biology. New York: John Wiley & Sons; 1-35
60. Rycyzyn MA, Clevenger CV 2002 The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer. Proc Natl Acad Sci USA 99:6790-6795
61. del Pozo MA, Price LS, Alderson NB, Ren X-D, Schwartz MA 2000 Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. EMBO J 19:2008-2014